Clinical Trial Update: To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks

View source ↗

Summary

Clinical trial update describing sildenafil therapy for eligible adults with pulmonary arterial hypertension over 112 weeks; study status completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Hypertension | Status: COMPLETED | Results posted: 2010-03-30